TCL Archive NCI Board of Scientific Advisors rejects the Institute’s $89 million proteomics research plan. March 11, 2005
TCL Archive Bristol-Myers Squibb Co. has agreed to pay $450 million to settle class action suits from shareholders and separate civil claims by the Securities and Exchange Commission. The settlements stem from Bristol’s practice of building up wholesalers’ inventories and diverting operating income to enhance dividends. August 6, 2004
TCL Archive Conversations With The Cancer Letter: Youle: ACS Stance on Tobacco Sales Is Clear April 18, 2014
TCL Archive An old drug’s 21st century makeover begins with 84-fold price increase. Price hike of procarbazine astonishes brain tumor specialists. May 13, 2005
